OK SB741

Pharmacists may test for and initiate drug therapy for minor, nonchronic health conditions (influenza, streptococcus, SARS-CoV-2, lice, and other public health threats identified by the State Commissioner of Health) under a standing order from a licensed physician or health department medical director

Tests used must be FDA-approved, cleared, or authorized under emergency use authorization, and must be CLIA-waived for patient care settings

Pharmacists are prohibited from testing or treating streptococcus in children under 6 years of age

Adds "minor, nonchronic health condition" as a new defined term in the Oklahoma Pharmacy Act and expands the definition of "practice of pharmacy" to include testing and initiating therapy for these conditions

Effective date: November 1, 2025